Russian ministry clarifies patented drugs production plan
This article was originally published in Scrip
Russia's ministry of industry and trade has clarified the recent announcement by Viktor Khristenko, the minister, that local companies will start manufacturing 15 innovative medicines, including those which are still under patent protection (scripnews.com, September 7th, 2009). Multinational pharmaceutical companies whose products appeared on Mr Khristenko's list said they knew nothing about the plan and learned about it from his presentation.
You may also be interested in...
Poland's president, Bronislaw Komorowski, has signed a reimbursement bill into the law which will come into force on 1 January.
In the past two years, most multinational pharmaceutical companies announced plans to create production facilities in Russia. They had been ignoring such an opportunity for years, and there were reasons for that. They included risks to investments, administrative barriers, unclear regulations assuming various interpretations and corruption.
Russia's president Dmitriy Medvedev has requested that his government start talks with the US and the EU on the mutual recognition of clinical trial results (including paediatric trials) and prepare proposals for corresponding amendments of existing regulations.